Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARY DAVIS

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Neonatal, Critical Care

NPI
1790320729
CMS profile
11119195
Location
JACKSON, MS

General Payments · PY2021–2024

$325.14

  • Reported across 19 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$256.36

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $256.36 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $256.36 16

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $14.97 1
PY2023 $53.81 2
PY2024 $256.36 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20212023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Takeda Pharmaceuticals U.S.A., Inc. $5.56 01/19/2024 Food and Beverage Undisputed 01/23/2026 1137732452 CMS
Takeda Pharmaceuticals U.S.A., Inc. $4.92 01/19/2024 Food and Beverage Undisputed 01/23/2026 1137732454 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.11 01/19/2024 Food and Beverage Undisputed 01/23/2026 1137732456 CMS
Takeda Pharmaceuticals U.S.A., Inc. $7.49 04/05/2024 Food and Beverage Undisputed 01/23/2026 1137732458 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.36 04/05/2024 Food and Beverage Undisputed 01/23/2026 1137732460 CMS
Takeda Pharmaceuticals U.S.A., Inc. $37.64 05/17/2024 Food and Beverage Undisputed 01/23/2026 1137732462 CMS
Takeda Pharmaceuticals U.S.A., Inc. $30.08 06/21/2024 Food and Beverage Undisputed 01/23/2026 1137732464 CMS
Takeda Pharmaceuticals U.S.A., Inc. $10.62 07/09/2024 Food and Beverage Undisputed 01/23/2026 1137732466 CMS
Takeda Pharmaceuticals U.S.A., Inc. $4.77 07/19/2024 Food and Beverage Undisputed 01/23/2026 1137732468 CMS
Takeda Pharmaceuticals U.S.A., Inc. $23.56 07/19/2024 Food and Beverage Undisputed 01/23/2026 1137732470 CMS
Takeda Pharmaceuticals U.S.A., Inc. $6.93 09/13/2024 Food and Beverage Undisputed 01/23/2026 1137732472 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.82 09/13/2024 Food and Beverage Undisputed 01/23/2026 1137732474 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.09 10/25/2024 Food and Beverage Undisputed 01/23/2026 1137732476 CMS
Takeda Pharmaceuticals U.S.A., Inc. $4.46 10/25/2024 Food and Beverage Undisputed 01/23/2026 1137732478 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.54 11/08/2024 Food and Beverage Undisputed 01/23/2026 1137732480 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.41 12/19/2024 Food and Beverage Undisputed 01/23/2026 1137732482 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.